Cord Blood Banking vs. Cord Tissue Banking
Americord provides you the opportunity to bank stem cells from both umbilical cord blood and umbilical cord tissue. Do you know what the differences are?
The types of stem cells found in cord blood and cord tissue is the main difference between them.
HSC vs MSC in Stem Cell Treatment
Hematopoietic stem cells (HSC) are found in the umbilical cord blood. These are the cells used in the treatment of over 80 conditions today and are the ones most commonly mentioned in the news. HSCs can develop into any blood component to help protect people from blood-related conditions and disorders including lymphoma and leukemia. In the cord tissue and placental tissue, there is a vast quantity of mesenchymal stem cells (MSCs), which can differentiate into many types of cells, including organ, muscle, skin, bone, cartilage, and fat cells. While no FDA-approved treatments exist using cord tissue or placental tissue stem cells today, research is growing at an incredible pace. MSCs are currently the subject of over 300 clinical trials and hold the promise of being able to someday treat debilitating conditions such as heart disease, Type 1 diabetes, lung cancer, Parkinson’s disease, and injuries to bones and cartilage.
Cord Blood vs Cord Tissue Banking, can you do both?
Right after a baby is born, you can bank both cord blood and cord tissue. Cord blood can help protect babies from 80+ different conditions already. Cord tissue banking is different because it has the potential to treat a much wider range of conditions and it can regenerate - meaning it can be used for multiple treatments.
Americord has competitive prices and flexible payment options for preserving stem cells from cord blood and cord tissue. We provide clients with both monthly and annual cord blood banking payment plans. We are also one of the only companies to provide the service of placenta tissue banking, another form of MSCs.
The views, statements, and pricing expressed are deemed reliable as of the published date. Articles may not reflect current pricing, offerings, or recent innovations.